Since the proportion of connective tissue mast cells in small airways correlated negatively with lung function, mast cell-derived IL-6 could be a target for inhibition in CF patients, especially considering successful use of IL-6 trans-signaling blockade in a mouse model of pulmonary fibrosis [84]. The gene discussed is IL6; the disease is cystic fibrosis.